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Abstract 
The solvent-free encapsulation of caffeine and kojic acid is carried out in different 
carboxylate-based MOFs (MIL-53(Al), UiO-66 and Mg-MOF-74) by high pressure (0.32 
GPa) contact. This methodology enables fast and ecofriendly encapsulation and gives 
rise to additive@MOFs with equivalent physical and features to materials obtained by 
common liquid phase encapsulation processes. It could be applied to other guest-host 
systems simplifying the procedures, reducing the use and waste of harmful chemicals 
and approaching the conditions of interest in the industry. The characterization carried 
out by thermogravimetry, X-ray diffraction, N2 adsorption and 13C NMR provided 
information about the presence and conformation of the additives in the MOFs. The 
highest encapsulation values for caffeine (37%) and kojic acid (32%) are obtained with 
MIL-53(Al). 
 






Metal-organic frameworks (MOFs) are porous crystalline hybrid materials made 
of metal ions or clusters coordinated with organic linkers to form single or 
multidimensional structures.1 Due to the high surface area  of these materials,2 their 
relatively high chemical and thermal stability3,4 and the possibility of modifying the pore 
size and the functionality by changing the metal ion or the organic ligand,5 MOFs are 
useful in a wide  range of fields such as catalysis,6 adsorption and storage of gases,7 
selective membranes,8 encapsulation,9 and medicine.10–13 
One of the most important families of MOFs corresponds to those based on 
carboxylate-type ligands. Specifically, MIL-53(Al), UiO-66 and Mg-MOF-74 are very 
suitable from the encapsulation point of view because of the potential biocompatibility 
of their corresponding organic linkers and metal centers.14,15 MIL-53(Al) is composed  of 
trivalent metal cations Al3+ interconnected through terephthalate linkers to form a three 
dimensional framework with rhombus-shape one-dimensional channels.16 This MOF has 
attracted considerable attention due to its high thermal and chemical stability and its 
“breathing” behavior. This allows it to adapt its porosity, which can vary in the range of 
8.5 x 8.5 Å (ht form) and 2.6 x 13.6 Å (lt form), to the size and shape of the guest 
molecule.16–18 This feature makes MIL-53(Al) very interesting in the encapsulation field19 
and for the delivery of molecules of pharmacological interest.17 The second carboxylate-
based MOF UiO-66 also shows  high stability  compared with other MOFs due to the 
special structure of the corresponding Zr4+-terephthalate, which displays octahedral and 
tetrahedral cages with triangular pore windows of 6 Å.20 The third material studied, Mg-
MOF-74, is composed  of Mg2+ and 2,5-dihydroxyterephthalate and presents hexagonal 
channels of 12 Å.21,22 This MOF is highly hydrated showing the behavior of a typical high 
aluminum content zeolite; due to the fact that some water molecules play a structural 
role, it has low stability in water.23 Finally, MIL-101(Cr) is made of terephthalate ligands 
coordinated to Cr3+ and is well-known as an adsorbent with a high specific surface area; 
it  has cages of 29 Å and 34 Å featuring 12 Å pentagonal and 16 Å hexagonal apertures.24 
Due to  its chromium content, this material is not as biocompatible as the other three 





Figure 1. Guest and host systems addressed in this work.  Atomic color code: carbon 
(grey), oxygen (blue) and metal coordination (green). These structures were made with 
Diamond 3.2. and Crystal Maker 9.2.7 using the corresponding CIF files.16,21,25,26 
 
Regarding traditional liquid phase encapsulation, there are two different 
methodologies to encapsulate a drug into a MOF denominated as “multi-step” and 
“one-step” encapsulations9,27–30 The former involves three steps: the synthesis of the 
MOF,  its subsequent activation, and the encapsulation of the drug by liquid phase 
adsorption.10,31–34 In the latter, the drug is placed together with the reactants in the 
synthesis media and the MOF grows around the drug.35–39 Moreover, after 
encapsulation, it has been reported the functionalization of MOF particles with different 
biomolecules40,41 and magnetic nanoparticles.42 Herein we propose a different and new 
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methodology: the solvent-free encapsulation by high pressure (0.32 GPa) contact of 
additives or drugs (caffeine and kojic acid) with several carboxylate-based MOFs (see 
Fig. 1). Caffeine can be considered as a model molecule31,35 suitable  for demonstrating 
a new encapsulation process. In addition, caffeine is widely known because of  its 
stimulant effect in the central nervous system43 but also as a fat reducer in the fields of 
cosmetics and pharmacology.44 To broaden the scope of applicability, a second probe 
additive, kojic acid, has been used in the present study. This natural compound 
produced by several fungi is used in low doses for skin lightening45,46 in cosmetic 
products and as an antimelanogenesis agent.47 It also has applications as a biocide.48 
The smaller molecular size of kojic acid (as compared to caffeine) will provide additional 
insight into the host-guest interaction.  
The solvent-free encapsulation process carried out for the first time in this work 
can be considered as environmentally friendly, in line with others related to the 
synthesis of MOFs working in continuous mode,49 using water as a solvent50 or avoiding 
the use of solvents entirely.49,50 We postulate that high pressure favors the diffusion of 
the additive into the material and therefore the use of any solvent is avoided. The 
bibliography on the effect of high pressure on MOFs is very scarce. We have previously 
reported the solvent-less synthesis of ZIF-8 at high pressure49 and  the behavior of this 
MOF at high pressure has also been described  with regard to its stability51,52 and water 
intrusion.53 Moreover, the contact of MOF Cu-btc with several liquids (alcohols and 
perfluorotri-N-pentylamine) has been studied up to 8 GPa.54 Interestingly, these authors 
concluded that “the fundamental understanding of high-pressure phenomena in MOFs 
will play a pivotal role in the advancement of their diverse applied functionalities.” 
Finally, it is worth mentioning that the MOFs studied here, MIL-53(Al),19 UiO-66,31,57 Mg-
MOF-7455 and MIL-101(Cr),56 have previously been applied to the conventional 
encapsulation of different guests.  Finally, it has been recently commercialized the MOF 
based products TruPick and ION-X as systems for food packaging and electronic gas 
delivery.57  In particular, TruPick releases 1-methylcyclepropene (encapsulated in a MOF 
synthesized by mechanochemistry) that reduces fruit ripening during its storage. This 
demonstrates that MOF encapsulation is a field with great potential of industrial 
development. 
 
Results and discussion  
Fig. 2 depicts the typical crystal morphologies of MIL-53(Al), UiO-66, Mg-MOF-74 
and MIL-101(Cr) as observed by SEM. These images are consistent with high crystalline 
materials (as demonstrated below by XRD characterization) which may be considered 
appropriate for the purpose of studying the solvent free encapsulation of caffeine and 




Figure 2. SEM images of the materials MIL-53(Al) (a), UiO-66 (b), Mg-MOF-74 (c) and 
MIL-101(Cr) (d). 
 
 High pressure stability and encapsulation  
In agreement with previous publications dealing with the liquid phase 
encapsulation of drugs in MOFs,19,31,32,35,37,57,61 XRD, N2 adsorption, NMR and TGA 
techniques were employed to evidence the encapsulation carried out here by the new 
solvent-free methodology proposed. XRD is qualitative proof of encapsulation, since the 
guest molecule intensity in its contact with the MOF decreases due the adsorption in 
the MOF structure. N2 adsorption (to calculate the BET specific surface area) is in line 
with XRD; if the encapsulation is produced in the MOF porosity, less porosity is available 
for N2 molecules. NMR demonstrates host-guest interactions and the preservation of 
the guest chemical nature. Finally, TGA allows a calculation of the encapsulation yield, 
since encapsulated molecules show a thermal stabilization as compared with external 
molecules (that have not penetrated in the MOF structure). We did not carry out liquid 
phase characterizations of our samples to avoid alteration of the solid state 
encapsulation method. 
Fig. 3 shows the diffraction patterns of the different materials before and after 
30 min at 0.32 GPa. As an index of the effect of pressure on the decrease of the MOF 
crystallinity, the FWHM (full width at half maximum height) was calculated for the main 
6 
 
peaks of the MOFs (MIL-53(Al): 12.5° - (110) plane, UiO-66: 7.2° - (111) plane, and Mg-
MOF-74: 11.7° - (300) plane) before and after pressure exposure. Table S1 shows the 
obtained results highlighting that the FWHM increased for the pressure treated 
materials in agreement with a decrease of crystallinity. In particular, MIL-53(Al) and Mg-
MOF-74 seem to be less affected, maintaining their crystalline structures after the high 
pressure treatment, even though the relative intensities of some peaks varied in the 
case of MIL-53(Al) probably due to its flexible structure.59 Regarding our results with 
UiO-66, low intensity peaks were still visible in the diffraction pattern after the high 
pressure treatment but with some noise and evident broadening (Table S1). Finally, 
strong amorphization was revealed for MIL-101(Cr) after the high pressure treatment 
treatment, and the FWMH was not calculated. Conspicuously characteristic peaks below 
10° disappeared while most of the others tended to merge into broad peaks. These 
findings are in agreement with previous works on computational characterization of the 
mechanical stability of flexible MIL-53(Al) and rigid UiO-66.60,61 These works predicted 
the loss of crystallinity of rigid UiO-66 at 1.83 GPa. In turn, this coincides with the 
experimental work carried out on UiO-66 that concluded that this MOF was not 
amorphized below 2 GPa, even though a gradual loss of crystallinity was detected at 
moderated pressures (0.3-1.7 GPa) in terms of broadening of the XRD peaks.62 
 
Figure 3. XRD patterns of the different samples (from bottom to top, MOF, MOF after 
high pressure exposure, caffeine@MOF after high pressure encapsulation, simple 
mixture of caffeine and MOF, and caffeine) corresponding to: MIL-53(Al) (a), UiO-66 (b), 








































































Mg-MOF-74 (c), and MIL-101(Cr) (d). Encapsulation at room temperature, 0.32 GPa and 
4:1 MOF:caffeine weight ratio. 
 
 XRD is a useful tool for monitoring the effective encapsulation of the additives 
since the additive intensities would decrease or almost disappear upon guest adsorption 
in the MOF porosity, i.e. the isolated additives in the MOF porosity would not be able to 
form detectable crystals. Fig. 3. shows the XRD patterns corresponding to the high 
pressure encapsulation of caffeine into the different MOFs (MOF:caffeine weight ratio 
of 4:1) together with those of the simple blending of caffeine with the MOF (at the same 
weight ratio) for a proper comparison. Encapsulation of caffeine in MIL-53(Al) and UiO-
66 produced a clear decrease in the main peak of caffeine at 11.9°, as inferred from the 
comparison of the XRD patterns corresponding to the simple additive-MOF mixtures and 
samples caffeine@MIL-53(Al) and caffeine@UiO-66. In consequence, this caffeine peak 
was considered to follow the encapsulation of caffeine in both MOFs. In this context, 
Table S2 shows the area ratios corresponding to maximum XRD peaks of additives 
(caffeine (CAF): 11.9° and kojic acid (KA): 19.3°) and MOFs (MIL-53(Al): 12.5° - (110) 
plane, UiO-66: 7.2° - (111) plane, and Mg-MOF-74: 11.7° - (300) plane) for simple 
additive-MOF blending (0 GPa) and encapsulation at 0.32 GPa. In all the cases, these 
area ratios decreased from the simple blending to 0.32 GPa encapsulation. We assume 
that this ratio decrease is due to the adsorption of caffeine into the MOF pores and 
therefore the disappearance of external caffeine impregnating the MOFs. 
Caffeine@MOF products would show the additive pattern if caffeine was present in the 
form of crystal outside the MOF. The reduction or absence of the characteristic caffeine 
peaks is consistent with its encapsulation, and the caffeine peaks are more evident when 
excess caffeine was used (2:1 MOF:caffeine weight ratio instead of 4:1, see Fig. S1). 
TGA analysis was used to observe the possible thermal stabilization of additives 
after encapsulation usually related to their adsorption on the MOF porosity and not to 
their mere external impregnation. The TGA curve of sample 4:1 in MIL-53(Al) (Fig. S2a) 
shows only one intermediate step corresponding to thermally stabilized caffeine. In the 
caffeine@UiO-66 TGA curve (Fig. S2b), two removal steps can be observed due to the 
external caffeine at ca. 180 °C and the encapsulated caffeine at ca. 230 °C. The external 
caffeine step appeared when caffeine was used in high excess, as seen in Fig. S3 for 
caffeine@MIL-53(Al). The XRD patterns for Mg-MOF-74 are not clear enough to 
conclude the completion of encapsulation because the most intense peak of caffeine 
overlaps with one of the peaks of the MOF. In addition, Fig. S2c does not reveal any 
stabilization for caffeine@MOF-74, in agreement with a mere external impregnation of 
caffeine on the MOF. In the pressurized sample with MIL-101(Cr), only caffeine peaks 
are observed, consistent with the great damage that the high pressure produced in this 
material, suggesting its structural collapse at 0.32 GPa. 
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Fig. 4 shows similar results for the encapsulation of kojic acid in MIL-53(Al) (Fig. 
4a) and UiO-66 (Fig. 4b). Nevertheless, the decrease corresponding to the kojic acid peak 
area is greater than in the experiments with caffeine as compared to the simple 
blending, especially in the case of MIL-53(Al) (Table S2). This can be attributed to the 
more reduced size of kojic acid (MW 142.11 g/mol) as compared to caffeine (MW 194.19 
g/mol), considering that it is easier to encapsulate a smaller molecule. However, the 
chemical interaction estimated in terms of Hansen solubility parameters9,63  would favor 
caffeine-terephthalate interactions (Ra parameter 3.1 MPa0.5) over those between kojic 
acid and terephthalate (9.6 MPa0.5). TGA curves in Fig. S4 show some thermal 
stabilization of kojic acid with both MOFs. In the case of Mg-MOF-74, the most intense 
peak of kojic acid remains in the kojic acid@Mg-MOF-74 (Fig. 4c). The area ratio 
between the most intense peaks of the additive at 19.3° and the MOF at 11.7° is 4.5 for 
the simple blending and 0.55 for kojic acid@MOF-74 (Table S2), i.e. an important part 
of the additive disappeared from the external surface during the encapsulation process. 
Therefore, in this case the change in the relative intensities supports the idea that 
encapsulation had taken place, in agreement with the corresponding TGA curve in Fig. 
S4c. MIL-101(Cr) was not used to encapsulate kojic acid due to its lack of high pressure 
stability, as shown above. 
 
Figure 4. XRD patterns of the different samples (from bottom to top, MOF, MOF after 
high pressure exposure, kojic acid@MOF after high pressure encapsulation, simple 
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mixture of kojic acid and MOF, and kojic acid) corresponding to: MIL-53(Al) (a), UiO-66 
(b), and Mg-MOF-74 (c). Encapsulation at room temperature, 0.32 GPa and 4:1 kojic 
acid:MOF weight ratio 
Table 1 shows the BET specific surface area values of some selected samples. 
First, the effect of high pressure reduced the surface area values for both MIL-53(Al) and 
UiO-66 from 1140 and 951 m2/g to 1016 and 253 m2/g, respectively. This suggests that 
the microporosity of MIL-53(Al) was not significantly affected by high pressure, in 
agreement with the above shown XRD pattern, while that of UiO-66 presents an 
important reduction, according to the somewhat noisy UiO-66 XRD pattern (suggesting 
some loss of crystallinity after the high pressure contact). In addition, the decrease of 
the BET specific surface area due to guest pore filling supports the encapsulation of 
caffeine and kojic acid in MIL-53(Al) and UiO-66, even though on this last case the effect 
of guess pore filing may overlap on the structure damage. The decrease of surface area 
of MIL-53(Al) (1016 m2/g) after the encapsulation of caffeine (336 m2/g) and kojic acid 
(9 m2/g) was consistent with its pores filled with the additives. These values were 52 and 
83 m2/g for caffeine@UiO-66 and kojic acid@UiO-66, respectively.  
 
Table 1. BET surface area of MIL-53(Al) and UiO-66 after high pressure treatment and 
high pressure encapsulation of caffeine and kojic acid in both MOFs. 
Sample SBET (m2/g) Sample SBET (m2/g) 
MIL-53(Al) 1140 UiO-66 951 
MIL-53(Al) HP 1016 UiO-66 HP 253 
Caffeine@MIL-53(Al) 336 Caffeine@UiO-66 52 
Kojic acid@MIL-53(Al) 9 Kojic acid@UiO-66 83 
 
Solid-state 13C NMR was employed to study the MOF-guest interactions upon 
encapsulation by high pressure contact. Figures 5 and 6 compare the 13C MAS NMR 
spectra of caffeine and kojic acid with those of MIL-53(Al) and UiO-66 before and after 
encapsulation. Some trends were observed analyzing the changes in chemical shifts of 
additives and terephtalate ligand in additive@MOF materials (Tables S3-S5).  In the case 
of caffeine@MIL-53(Al), the peaks corresponding to the terephthalate MOF linker 
remained as in the bare MIL-53(Al) (Table S3a). However, the peaks of caffeine were 
modified once it was encapsulated (see Fig. 5a and Table S4). Interestingly, C2, C4, C5, 
Me1 and Me6 signals shifted upfield, while those for C7, C9 and Me3 shifted downfield. 
This can be explained by the anisotropic magnetic behavior of the ligand. There are 
typical shielding areas due to the aromatic ring effect (affecting to upper and lower 
parallel planes) and also deshielding zones (anisotropic cone) generated by the carbonyl 
group. Therefore, the size and shape of the guest molecule and host cages determine a 
specific and symmetric position of caffeine inside the porosity of MIL-53(Al). An 
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arrangement of caffeine-terephthalate planes with C2-axis of terephthalate parallel to 
an imaginary line bonding N8 and N1 in caffeine ring (Fig. 5c) is proposed for 
caffeine@MIL-53(Al). However, the symmetry of the MOF linker is not affected and the 
13C NMR peaks are similar to those of the bare MIL-53(Al).  
Caffeine@UiO-66 exhibits 13C NMR peaks corresponding to the MOF ligand wider 
as compared to the bare UiO-66 (Figure 5b). This agrees with the loss of crystallinity 
after the encapsulation process and with the XRD results and BET specific surface area 
values above discussed. Nevertheless, taking into account the observed changes in the 
chemical shifts of caffeine and ligand signals, a complementary explanation is proposed. 
A similar trend of caffeine signals in both MIL-53 and UiO-66 (Table S4) shows a parallel 
arrangement between additive and terephthalate ligand in both MOFs. Simultaneously, 
the slight tendency to downfield of broadened carboxylate signal of ligand (a shoulder 
can even be observed at 172.3 ppm, Table S3b) next to a deshielding of Corto suggests 
the formation of hydrogen bonds that involve the carboxylic group of terephthalate. 
Simultaneously, the amorphization of caffeine@UiO-66 and the different kind of host-
guest interactions may increase the anisotropy of the host giving rise to the observed 
broad peaks. 
 
Figure 5. 13C MAS NMR spectra of the different samples (from bottom to top, MOF, 
caffeine@MOF after high pressure encapsulation and caffeine) corresponding to: MIL-
53(Al) (a), and UiO-66 (b). Encapsulation at room temperature, 0.32 GPa and 4:1 
caffeine:MOF weight ratio. Proposed arrangement of caffeine-terephthalate planes 
with C2-axis of terephthalate parallel to an imaginary line bonding N8 and N1 in caffeine 
ring. Color code: upfield atoms (blue) and downfield atoms (red) (c). 
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For kojic acid@MIL-53(Al) the terephthalate 13C NMR signals were also widened 
(see Fig. 6a and Table S5) as compared to those of kojic acid and MIL53(Al). This is 
attributable to the host-guest interactions because the MIL-53(Al) structure was 
preserved after the high pressure treatment, in agreement with both XRD and N2 
adsorption characterizations. The chemical 13C NMR signals of terephthalate in kojic 
acid@MIL-53(Al) followed a different pattern from those of caffeine@MIL-53(Al) and 
kojic acid@UiO-66 (Table S5), and carboxylate and Corto signals of ligand shifted upfield. 
This behavior suggests that the presence of the additive modifies the metal-
terephthalate interactions. It has been described that changes in binding modes of the 
acetate group in metallic clusters can be determined using the solid-state 13C NMR: 
carboxylate peak shifts upfield when it changes from chelating mode to bidentate or 
monodentate bridge.64 This change in metal-terephthalate binding must be due to the 
effect of kojic acid. It is known that kojic acid forms stable chelates with metal acetate 
salts.65 Nevertheless, the suggested interactions are reversible, as the 
thermodiffractometry experiments suggests (see below). 
Finally, the chemical 13C NMR peaks of terephthalate in kojic acid@UiO-66 did 
not broaden suggesting ordered host-guest interactions (Fig. 6b and Table S5). 
Carboxylate and Corto signals of ligand were deshielded evidencing the formation of 
hydrogen bonds between carboxylic groups of terephthalate and hydroxyl groups of 
kojic acid. A slightly shielding of carbon atoms of kojic acid suggests an additional 
stacking of the aromatic rings of both structures in parallel planes. The behavior of 
carbonyl C4 in kojic acid is different because it is the most electronically affected by the 
intermolecular hydrogen bond with terephthalate, since it must loss its intramolecular 
hydrogen bond. These kojic acid-UiO-66 interactions could preserve the symmetry of 
the linker and the ordered structure of MOF, in agreement with 13C NMR spectra. 
 
Figure 6. 13C MAS NMR spectra of the different samples (from bottm to top, MOF, kojic 
acid@MOF after high pressure encapsulation and kojic acid) corresponding to MIL-
53(Al)(a), and UiO-66 (b). Encapsulation at room temperature, 0.32 GPa and 4:1 kojic 
acid:MOF weight ratio.  
12 
 
Table 2 shows the encapsulation values achieved with the different MOFs. The 
calculation was made per g dry MOF, i.e. excluding from the curves in Figs. S1 and S3 
solvent (in principle water from moisture) and external (non-encapsulated) additive 
weight losses below ca. 100 °C and above the removal temperature of the pure additive, 
respectively. The material that produced the best results was MIL-53(Al), with 37% and 
32% loadings for caffeine and kojic acid, respectively. This can be related to  its 
exceptional stability against mechanical treatment and the  flexibility of its structure,16 
which facilitates the successful encapsulation of the two different additives, caffeine and 
kojic acid. Additionally, UiO-66 showed 15% and 22% loadings for caffeine and kojic acid, 
respectively, but the loadings (probably due to its small porosity and lack of flexibility) 
and the mechanical stability (see the above XRD discussion) were lower than in the case 
of MIL-53(Al). Mg-MOF-74 has been demonstrated to be stable at high pressure and the 
encapsulation seems to be achieved only for kojic acid (24%) under the experimental 
conditions tested. The encapsulation in Mg-MOF-74 involves the exchange of water 
(present in the as-made MOF, as shown in Fig. S2c with the first step around 100 °C) by 
the desired guest, and only kojic acid was able to produce such an exchange. Table 2 
also shows the number of molecules of additive per unit cell (u.c.): 1.6 and 1.3 
molecules/u.c. for caffeine@MIL-53(Al) and caffeine@UiO-66, respectively, and 1.9, 2.5 
and 2.1 molecules/u.c. for kojic acic@MIL-53(Al), kojic acid@UiO-66 and kojic acid@Mg-
MOF-74, respectively. For the corresponding calculations, the unit cell formulae of 
C32Al4O20H20 (MIL-53(Al)),16 C192Zr24O120H96 (UiO-66)20 and C16Mg16O40H8 (Mg-MOF-74)25 
were used .This means that the wt% loading corresponding to one molecule per u.c. is 
23, 12 and 16 wt% in case of caffeine and 17, 8.7 and 12 wt% in case of kojic acid for for 
MIL-53(Al), UiO-66 and Mg-MOF-74, respectively. 
 
Table 2. Caffeine and kojic acid encapsulation in different MOFs at 0.32 GPa with 4:1 
MOF:guest weight ratio and room temperature in (g guest/g dry MOF)·100 and number 
of additive molecules per unit cell (molec./u.c.). The unit cell formulae of C32Al4O20H20, 
C192Zr24O120H96 and C16Mg16O40H8 have been considered for MIL-53(Al),16 UiO-6620 and 
Mg-MOF-74,25 respectively, for the calculations. 
















3.2 Effect of temperature and pressure on the encapsulation in MIL-53(Al) 
 MIL-53(Al) is sensitive to temperature16,66 and a sufficiently high temperature  
may help the desorption of the guest. We have therefore observed the effect of 
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different temperatures on high pressure encapsulation samples in 
thermodiffractometry experiments. Fig.7 shows the diffraction patterns measured in 
the 25-300 °C range. When increasing the temperature from 50 to 100 °C, the 
caffeine@MIL-53 sample changed its structure from the hydrated, low temperature 
form (MIL-53(Al) lt) to the high temperature form (MIL-53(Al) ht,16 maintained upon 
heating up to 300 °C), while caffeine peaks are  scarcely apparent. However, the TGA 
analyses carried out on pure caffeine and caffeine@MIL-53 are consistent with the 
removal of caffeine at a temperature higher than 100 °C (Fig. S2a). This suggests that 
the action of the high temperature favors the encapsulation of caffeine guest molecules 
placed in the surroundings of caffeine@MIL-53. This can be considered as a process in 
series. First, the high temperature increases the mobility of caffeine molecules already 
encapsulated, but occupying mostly external crystal pores and eventually reaching 
empty internal crystal pores. Second, caffeine molecules impregnating the external 
surfaces of MIL-53 crystals penetrate inside the porous structure.  
In the case of the kojic acid@MIL-53 sample, the phase transition is also observed 
(Fig. 7). Additionally, the complexity of the peaks is considerably increased at 150 °C. We 
assume that the molecule of kojic acid interacts with the functional groups in the pores 
and, as occurs with water molecules, the structure changes according to this stimulus. 
The recovery of the structure of MIL-53(Al) ht upon heating at 300 °C is consistent with 
a reversible encapsulation process in both caffeine@MIL-53 and kojic acid@MIL-53 
samples. These results are completed with the thermodiffractometries corresponding 
to the encapsulations of caffeine and kojic acid on UiO-66 and Mg-MOF-74 (Fig. S5). 
  
Figure 7. Thermodiffractometry in air with a heating ramp of 10°C/min of caffeine@MIL-
53(Al) (a) and kojic acid@MIL-53 (b). Encapsulation at 0.32 GPa and with a 4:1 
MOF:guest weight ratio.  
 
Once demonstrated the new solventless application, to gain insight into the 
encapsulation at high pressure and the impact of temperature, the influence of a small 
amount of ethanol in the encapsulation of caffeine in MIL-53(Al) was investigated. After 
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the addition, the mixture was still a solid considering the small amount of ethanol used 
in the experiment. This would improve the additive-MOF contact and hence the 
diffusion and dispersion of the additive into the pores of the MOF. Fig. S6 shows a more 
complex XRD pattern compared to those of the as-made material and those 
encapsulated without ethanol (Fig. 3a). As mentioned above, MIL-53(Al) “breathes” 
depending on the presence of guest molecules in the pores of the MOF, and as a 
consequence the diffraction pattern was modified. In this experiment, caffeine and 
ethanol were simultaneously adsorbed on the material evidencing changes in the XRD 
intensities, consistent with an opening (as compared with the lt as-made material) of 
the porosity as observed for MIL-53(Cr) when adsorbing methanol and ethanol.67 
The sample caffeine@MIL-53(Al), obtained in the presence of ethanol, was used 
in a thermodiffractometry experiment carried out under vacuum. Together with this 
sample, Fig. S6 shows for the purposes of comparison the XRD patterns of caffeine and 
MIL-53(Al) at the initial conditions previous to the encapsulation, i.e. in the form known 
as lt.16 Upon heating at 200 °C, the ethanol was desorbed from the MOF and the XRD 
adapted the ht form for MIL-53(Al).68 After subsequent heating at 300 °C, caffeine 
should have been removed (in agreement with the TGA shown in Fig. S7); however, no 
further changes were observed in the XRD pattern. 
Finally, even though most of the encapsulation experiments were carried out at 
0.32 GPa, Tables S6 and S7 and Fig. S8 show the encapsulation of caffeine and kojic acid 
on MIL-53(Al) at three different pressures from 0.32 to 0.64 GPa. The decrease of the 
percentage of encapsulation (MIL-53(Al)) and the similar values of BET specific surface 
area observed with increasing pressure suggest that 0.32 GPa was the optimum working 
pressure. This pressure relates to a good balance between the loss of MOF crystallinity 
and the encapsulation efficiency. 
 
Conclusions 
We have demonstrated the simple and ecofriendly encapsulation of caffeine in 
two different MOFs by means of a high pressure application (0.32 GPa). This simple 
procedure may be of considerable industrial interest considering its speed and the fact 
that it does not need further purification (i.e. separation from the encapsulation 
dispersion as in the case of conventional liquid phase encapsulation). This minimizes the 
use of solvents and the potential generation of waste. Moreover, the solvent free, high 
pressure approach has been carried out with three MOFs (MIL-53(Al), UiO-66 and Mg-
MOF-74, since MIL-101(Cr) was strongly amorphized upon high pressure exposure) and 
two guests (caffeine and kojic acid), the best results being obtained with MIL-53(Al) due 
probably to its high structural flexibility that helps the diffusion of caffeine under the 
pressure effect. The XRD characterization demonstrated the encapsulation qualitatively, 
while TGA allowed to estimate of the amount of drug encapsulated in every case. In 
addition, the decrease of the BET specific surface area of MOFs after the encapsulation 
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of caffeine and kojic acid was consistent with its pores filled with the additives. The 13C 
MAS NMR spectra of the additive@MOF materials support the preservation of the 
chemical nature of caffeine and kojic acid upon high pressure encapsulation, suggesting 
in some cases (caffeine@MIL-53(Al) and kojic acid@UiO-66) relatively ordered host-
guest interactions. The combination of the four characterization techniques 
demonstrated both the qualitative and quantitative caffeine and kojic acid 
encapsulation in the studied MOFs using the at high pressure conditions in solvent-free 
conditions. Finally, the results achieved with this research, obtained through a green 
process, allow one to say that MOF encapsulation is a field with great potential of 
industrial development where the costs and environmental impacts can be minimized. 
 
Experimental section 
Synthesis of materials 
Synthesis of MIL-53(Al). In a typical synthesis,16 5.20 g of aluminum nitrate 
nonahydrate (13.9 mmol, Al(NO3)3·9H2O, Sigma Aldrich, ≥98%) together with 1.12 g of 
terephthalic acid (6.7 mmol, H2BDC, Sigma Aldrich, 98%) were dispersed in 100 mL of 
distilled water and placed in a Teflon-lined stainless steel autoclave for 3 days at 220 °C. 
The resulting product was recovered by centrifugation at 10,000 rpm for 10 min, washed 
once with ethanol followed by centrifugation under the same conditions and dried 
overnight at 65 °C. The solid was activated by calcination at 380 °C for 24 h. 
Synthesis of UiO-66. Following a previous report,20 0.508 g of ZrCl4 (2 mmol, 
Sigma Aldrich, ≥99,5 %) and 0.667 g of terephthalic acid (4 mmol, H2BDC, Sigma Aldrich, 
98%) were mixed with 100 mL of dimethylformamide (DMF) and the resulting solution 
placed in a Teflon-lined stainless steel autoclave for 24 h  at 120 °C. The white product 
was recovered by centrifugation at 10,000 rpm for 10 min and washed once with ethanol 
followed by centrifugation under the same conditions. The solid was activated by 
calcination at 300 °C for 4 h. 
Synthesis of Mg-MOF-74. As reported elsewhere,21 0.149 g of 2,5-
dihydroxyterephthalic acid (0.75 mmol, DOBDC, TCI, >98%) was dissolved in 10 mL of 
THF  after which 3 mL of a 1 M NaOH aqueous solution was added. A solution of 0.384 g 
of magnesium nitrate hexahydrate (1.5 mmol, Mg(NO3)2·6H2O, Sigma Aldrich, 98%) in 3 
mL of distilled water was added and the resulting mixture placed in a Teflon-lined 
stainless steel autoclave for 3 days at 110 °C. The yellow product was recovered by 
centrifugation at 10,000 rpm for 10 min and washed several times with methanol 
followed by centrifugation under the same conditions. The product was dried overnight 
at room temperature. 
Synthesis of MIL-101(Cr). Following a previous report,69 0.83 g of terephthalic 
acid (5 mmol, H2BDC, Sigma Aldrich, 98%) and 2.00 g of chromium nitrate nonahydrate 
(5 mmol, Cr(NO3)3·9H2O, Sigma Aldrich, 98%) were mixed in 25 mL of distilled water and 
placed in a Teflon-lined stainless steel autoclave for 8 h at 220 °C. The green product 
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was recovered by centrifugation at 10,000 rpm for 10 min and washed with methanol 
followed by centrifugation under the same conditions. The solid was activated by 
treatment in DMF for 24 h at 150 °C and then boiled in a reflux in methanol overnight. 
The product was dried at room temperature for 8 h. 
 
High pressure encapsulation 
The procedure for the high pressure encapsulation was as follows: 100 mg of the 
MOF material and 25 mg of additive (weight ratio 4:1) were mixed together by 1 min 
hand shaking in a vial. The mixture was then placed at room temperature inside the 
metal cylinder of a hydraulic press (Specac 25.011). After insertion of the metal piston, 
pills were compacted under a pressure of 0.32-0.64 GPa for 30 min. The compacted 
material pill was gently milled into powder and is referred to here as additive@MOF. 
Blanks corresponding to the MOFs and additives separately exposed to high pressure 
were produced under the same conditions. Additionally, in the case of MIL-53(Al), 2:1 
and 1:1 MOF:additive weight ratios were contacted at high pressure. Finally, a 2:1 
weight ratio experiment was carried out at 0.32 GPa for 30 min with the addition of 20 
mg (ca. 0.025 mL) of ethanol, i.e. using a 2:1:0.4 MOF:additive:ethanol weight ratio. 
  
Characterization 
Scanning electron microscopy (SEM, FEI Inspect F50) observation of the powder 
samples was carried out with a voltage 2-15 kV and after Pt coating. Powder X-ray 
diffraction (XRD) was carried out at room temperature in a Siemens diffractometer with 
a copper anode and a graphite monochromator so as to select Cu-Kα1 radiation (λ=1.540 
Å). Data were collected in the 4-40° 2θ range, and the scanning rate was 0.03°/s. This 
technique was used to check the crystallinity after the process and to observe the 
decrease of additive peaks in high pressure contact encapsulation due to the reduction 
of the external additive. Nitrogen adsorption isotherm and BET specific surface area 
were measured with a Micrometrics TriStar 3000 with a previous degasification at 150 
°C for 5 h.  The 13C NMR spectra were achieved with cross-polarized magic angle spinning 
solid nuclear magnetic resonance (CP MAS-NMR) in a Bruker Avance III WB 400. 
Thermogravimetric analyses (TGA) were performed using Mettler Toledo TGA/SDTA 
851e instrument. The samples were put in 70 µL alumina pans and heated up to 700 °C 
with a heating rate of 10 °C/min in air. Thermodiffractometry was performed under air 
in a furnace coupled to a Siemens diffractometer with a copper anode and a graphite 
monochromator to select the same Cu-Kα1 radiation. Each XRD pattern was recorded for 
20 min in the 3-40° 2θ range with a 0.01°/s scanning rate at 25, 50, 100, 150, 200, 250 
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